Lynx1 Capital Management LP

Lynx1 Capital Management LP (10% owner) filed 2 Form 4 reports as a reporting entity in the trailing twelve months (2 purchases, 0 sales), most often in Passage Bio, Inc. (PASG). Across 1 priced purchase filing, the average 21-session return was +1.5% from execution and -0.7% from disclosure (delay-adjusted; derived). The largest single filing was $854K of KRRO (77,299 sh across 3 lots, as filed), executed Oct 22. Data as of Nov 8 2026.

Median ADV $2.6M across their filed names

50% of their measured filings could not be priced (delisted or unquoted names). The returns above cover only what still trades.

Derived: compounded across filings from disclosure dates · past 12 months